| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Creativity and Innovation Management - Personality Testing |
|
Just Other Articles - Creativity and Innovation Management - Personality Testing
Whilst tests measuring the creative or innovative personality exist, there are a number of inherent According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product flaws. Some are noted below: a) Whether a creative or innovative type exists at all is highly con ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in entious. Creativity can be defined as problem identification and idea generation – universal abilit lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. es. Creativity can be defined as producing a number of ideas, a number of diverse ideas and a numbe here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe of novel ideas – universal abilities. Traits are not stable or transferable across situations. Mot d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro vation is a critical factor. b) Due to the numerous relevant definitions of creativity and innovat ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc on, it is clear that a number of differing and distinct competencies are involved. It is unlikely ( easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi r rare) that all competencies are present in single individual. c) Creativity is a cognitive proce nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically s and case dependent. Not all people produce equal quantities of ideas across tasks and, importantl and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ , the same people do not produce equal quantities of ideas across tasks. d) Too many assumptions a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e made. Some have been indicated : the assumption that creativity and innovation are stable and tra ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nsferable across situations ; motivation and competencies are not accounted for etc etc etc. e) Co dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod laboration, networking and such are ignored. Intellectual cross pollination results in a higher deg cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ee of creative output than is produced by individuals alone. f) The generalisability, variability tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nd reliability of the test paramters can be disputed. These topics are covered in depth in the MBA t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel dissertation on Managing Creativity & Innovation, which can be purchased (along with a Creativity a ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust d Innovation DIY Audit, Good Idea Generator Software and Power Point Presentation) from y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products new" href="http://www.managing-creativity.com">http://www.managing-creativity.com. You can als . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de receive a regular, free newsletter by entering your email address at this site. You are free to r elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip produce this article as long as no changes are made and the author's name and site URL are retained tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Mergers and Acquisitions Reports Are You Putting Your Stock, Facilities or Even Workers' Lives at Risk, by Ignoring Hazardous Goods? Success Strategies For Landing Your Dream Job!
|